Global Biotech Investment Report 2024 - Big Biopharma Companies Disruptive Technologies and Portfolio Realignment Will Ensure the Growth Potential of Biotech Investments - ResearchAndMarkets.com
In this analysis, the report provides critical insights into the biotech M&A and venture capital (VC) investment, highlighting the drivers, challenges, predictions, and major trends in the biotech segment. This analysis also identifies actionable growth opportunities for industry participants to leverage.
To understand the trend outlook for 2024 and beyond, this analysis assesses strategic and financial investments, mergers and acquisitions (M&A), VC investments, and private equity (PE) from 2019 to 2023. The analyst has gathered the total numbers for the entire ecosystem. The scope of this analysis is global, with 2023 as its base year, and includes forecasts up to 2028.
Featured Companies:
Alexandria
ARCH Ventures
Google Ventures
OrbiMed
RA Capital
SamsaraBio Capital
Key Topics Covered:
Growth Generator
Growth Drivers
Growth Restraints
The State of the Biotech Industry - Biologics Pipeline
State of the Biotech Industry - Biologics Industry Outlook
Biotech M&A Investment Outlook - 2024
Biotech VC Investment Outlook - 2024
Top 3 Predictions - 2024
Top 3 Big Pharma Investment Strategies for Portfolio Remodeling
Emerging Biotech Companies Top Trends - Impact Summary
New Modalities Driving Precision Medicine Will Remain Attractive
Investors Prioritizing Cardiometabolism, Oncology, CNS, and Immunology
Growth Generator: Biotech M&A
Biotech M&A Trends
Big Biopharma M&A Activity
Biotech M&A Analysis by Therapeutic Segment
Biotech M&A Analysis by Modality
Key Biopharma M&A Targets 2024
Growth Generator: Biotech VC Investment
Biotech VC Financing Trend
Top VC Financing Deals
Biotech VC Deal Analysis by Funding Stage
Biotech VC Deal Analysis by Therapeutic Segment
Biotech VC Deal Analysis by Modality
Biotech VC Deal Analysis by Stage of Clinical Development
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Please be advised that the Honourable Patty Hajdu, Minister of Indigenous Services, will make a funding announcement for the Weeneebayko Area Health Authority.
Date: Monday, June 17, 2024Time: 12:00 p.m. (ET)
Where:House of Commons Foyer (West...
Today, Crisis Prevention Institute (CPI) announced the launch of Reframing Behavior ? its new groundbreaking, subscription-based, schoolwide training program that unpacks the latest neuroscience to help all educators build a more positive, supportive...
Positive results from the ECHO Phase III trial showed AstraZeneca's CALQUENCE® (acalabrutinib) in combination with bendamustine and rituximab demonstrated a statistically significant and clinically meaningful improvement in progression-free survival...
Electra Therapeutics, Inc., a clinical stage biotechnology company developing antibody therapies against novel targets for immunological diseases and cancer, announced the presentation of clinical data for ELA026 in secondary hemophagocytic...
The University of California, Irvine has received a $50 million donation from Orange County biotech entrepreneur Charlie Dunlop for the School of Biological Sciences. His gift will create an endowed fund that will provide unrestricted support for...
Please be advised that the Honourable Patty Hajdu, Minister of Indigenous Services, will make a funding announcement for the Weeneebayko Area Health Authority.
Date: Monday, June 17, 2024Time: 12:00 p.m. (ET)
Where:House of Commons Foyer (West...